Literature DB >> 9327506

Neuropathology of schizophrenia: cortex, thalamus, basal ganglia, and neurotransmitter-specific projection systems.

S Heckers1.   

Abstract

This article reviews neuropathological studies in the search for an anatomical correlate of schizophrenia. Replication of many results has proven to be difficult. A consistent finding is the lack of significant gliosis in the neocortex. Intriguing findings that need further corroboration include decreased volume and cell number of the mediodorsal thalamic nucleus, cytoarchitectural alterations of the prefrontal cortex and upper layers of the anterior cingulate gyrus, and superior temporal gyrus abnormalities. Most neuropathological studies investigate regional brain volume and cell density. Highly variable shrinkage of brain tissue postmortem makes these estimates prone to bias and often not comparable across studies. So far, no strong clinicopathological correlations and no pathological criteria to diagnose schizophrenia have been established.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9327506     DOI: 10.1093/schbul/23.3.403

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  31 in total

Review 1.  Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia.

Authors:  C Konradi; S Heckers
Journal:  Biol Psychiatry       Date:  2001-11-15       Impact factor: 13.382

Review 2.  Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment.

Authors:  Christine Konradi; Stephan Heckers
Journal:  Pharmacol Ther       Date:  2003-02       Impact factor: 12.310

Review 3.  Testing models of thalamic dysfunction in schizophrenia using neuroimaging.

Authors:  K Sim; T Cullen; D Ongur; S Heckers
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

4.  Molecular components of striatal plasticity: the various routes of cyclic AMP pathways.

Authors:  A Rajadhyaksha; J Leveque; W Macías; A Barczak; C Konradi
Journal:  Dev Neurosci       Date:  1998       Impact factor: 2.984

Review 5.  Neurodevelopment, GABA system dysfunction, and schizophrenia.

Authors:  Martin J Schmidt; Karoly Mirnics
Journal:  Neuropsychopharmacology       Date:  2014-04-24       Impact factor: 7.853

Review 6.  The potential role of lamotrigine in schizophrenia.

Authors:  Charles H Large; Elizabeth L Webster; Donald C Goff
Journal:  Psychopharmacology (Berl)       Date:  2005-10-12       Impact factor: 4.530

7.  Imaging frontostriatal function in ultra-high-risk, early, and chronic schizophrenia during executive processing.

Authors:  Rajendra A Morey; Seniha Inan; Teresa V Mitchell; Diana O Perkins; Jeffrey A Lieberman; Aysenil Belger
Journal:  Arch Gen Psychiatry       Date:  2005-03

8.  Neuroanatomical correlates of psychopathology in antipsychotic-naïve schizophrenia.

Authors:  Ganesan Venkatasubramanian
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

9.  Neuregulin 3 Knockout Mice Exhibit Behaviors Consistent with Psychotic Disorders.

Authors:  Lindsay N Hayes; Alexey Shevelkin; Mariela Zeledon; Gary Steel; Pei-Lung Chen; Cassandra Obie; Ann Pulver; Dimitrios Avramopoulos; David Valle; Akira Sawa; Mikhail V Pletnikov
Journal:  Mol Neuropsychiatry       Date:  2016-05-20

10.  Prefrontal cortical thickness in first-episode psychosis: a magnetic resonance imaging study.

Authors:  Laura C Wiegand; Simon K Warfield; James J Levitt; Yoshio Hirayasu; Dean F Salisbury; Stephan Heckers; Chandlee C Dickey; Ron Kikinis; Ferenc A Jolesz; Robert W McCarley; Martha E Shenton
Journal:  Biol Psychiatry       Date:  2004-01-15       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.